No CrossRef data available.
Article contents
NIH Licensing Would Benefit from Free-Market Provisions
Published online by Cambridge University Press: 04 March 2024
Abstract
Government encouragement of free markets is a highly effective means of fostering pharmaceutical innovation; the NIH, by including “free-market provisions” in its licensing agreements that discourage anti-competitive and research-impeding behavior, can do a great deal to support this goal even without legislative overhaul.
- Type
- Commentary
- Information
- Copyright
- © 2023 The Author(s)